Navigation Links
BioMed Realty Trust Reports Third Quarter 2010 Financial Results
Date:11/3/2010

to common stockholders

$  4,832

$  4,062

$  13,331

$  41,282Adjustments:Noncontrolling interests in operating partnership

122

122

359

1,502Interest expense on exchangeable senior notes due 2030 (1)

1,681

-

4,875

-Depreciation and amortization — unconsolidated partnerships

835

662

2,192

1,986Depreciation and amortization — consolidated entities

27,774

30,953

83,159

82,767Depreciation and amortization — allocable to noncontrolling interest of consolidated joint ventures

(24)

(20)

(67)

(58)Funds from operations available to common shares and Units

$  35,220

$  35,779

$  103,849

$  127,479Funds from operations per share — diluted

$  0.28

$  0.35

$  0.86

$  1.37Weighted-average common shares and Units outstanding — diluted (2)

127,053,959

101,289,458

121,191,848

92,863,08
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications
2. BioMed Realty Trust Completes South San Francisco Portfolio Acquisition
3. BioMed Realty Trust to Report 2010 Third Quarter Results
4. BioSpace and BioMed Central Create Global Career Community
5. DSM Biomedical Announces Continued Partnership with Spinelab
6. BioMed Realty Trust Declares Second Quarter 2010 Common Stock and Preferred Stock Dividends
7. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
8. BioMed Realty Trust Promotes Greg Lubushkin to Chief Financial Officer
9. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
10. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
11. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 At the ... has granted a 60-day extension for the public comment ... Special Rule for Model Aircraft established by Congress as ... 2012. The 60-day extension establishes the new deadline for ... States Department of Transportation/FAA notice published in the Federal ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... Gain recognition for leadership and ... the biotech industry. Nominations are now being accepted ... you by the Bio Supply Management Alliance ... management professionals for the past 7 years. , ... Biotech industry – Manufacturers, Service Providers, Material Suppliers, ...
(Date:7/24/2014)... 24, 2014  Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), ... of regenerative medicine, announced today that it will ... investors on Tuesday, July 29, 2014, at 4:30 ... include an overview of Asterias, business strategy and ... http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes before ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... database to explore, understand, manage, and share next-generation ... Inc., the leader in sequence data management, today ... Expression Workflow designed to enable researchers working with ... is the second such workflow to be delivered ...
... May 5 Sequella, Inc., a clinical-stage biopharmaceutical company ... start of its Phase 1B trial for SQ109 with ... a new diamine antibiotic intended to replace one or ... patient therapy, was granted U.S. FDA Fast Track designation ...
... influenza virus-like particle (VLP) vaccine progresses with study designed ... May 5 Novavax, Inc. (Nasdaq: NVAX ... second clinical trial of its virus-like particle (VLP) seasonal ... this Phase II randomized, placebo controlled clinical trial has ...
Cached Biology Technology:GenomeQuest, Inc. Announces Digital Gene Expression Solution Within Its Sequence Data Management Platform 2Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 4
(Date:7/25/2014)... N.Y., July 25, 2014 In the first broad-scale estimate ... Service scientists and collaborators calculated that trees are saving ... 670,000 incidences of acute respiratory symptoms. , While trees, ... of less than 1 percent, the impacts of that ... of the reduced air pollution at nearly $7 billion ...
(Date:7/25/2014)... era, 100,000s of people lived on the land now ... to control the availability of plants they used for ... use fire to maintain desired habitat and natural resources. ... Service,s Pacific Southwest Station, will lead a field ... during the Ecological Society of America,s 99th Annual Meeting, ...
(Date:7/25/2014)... from the Terra satellite show the different areas that have ... Russia. The burn scars show up as reddish-brown splotches ... broken across the remote parts of Eastern Russia in the ... MODIS instrument, it is still possible to see the ... features noted below show the devastating number of fires that ...
Breaking Biology News(10 mins):First national study finds trees saving lives, reducing respiratory problems 2Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3
... at Chapel Hill shows how a protein may be crucial ... protein, called "eed," is needed for an essential chemical modification ... findings appear in the May 24 issue of the journal ... a new wave of thinking in genetics: that not all ...
... most, the mere mention of the word "virus" stirs ... suffering. But in recent years, scientists have been trying ... the fight against cancer. , Through genetic engineering, viruses ... abilities to infiltrate, commandeer, replicate and destroy, but only ...
... Howard Hughes Medical Institute have succeeded in mapping the ... range of odors, including vanilla, skunk, fish, urine, musk, ... of neural activity represents a significant step in understanding ... in the nose into odor perception in the brain, ...
Cached Biology News:Protein helps regulate the genes of embryonic stem cells 2Turning viruses into allies against cancer 2Turning viruses into allies against cancer 3Turning viruses into allies against cancer 4Decoding the logic of olfaction 2Decoding the logic of olfaction 3Decoding the logic of olfaction 4
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Hamamatsu C9136 FLIM system combines the space and ... the resolution of the optical microscope to open ... short, pulsed light source for excitation, the decay ... the lifetime of the decay measured. Subtle ...
... ScriptCap™ m7G Capping system features ... all of the components needed ... on the end of di- ... kits feature high efficiency capping ...
Extracti-Gel D Detergent Removing Gel...
Biology Products: